Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):451–453. doi: 10.1097/PAI.0b013e31824bb404

FIGURE 1.

FIGURE 1

Membranous/cytoplasmic immunostaining for hKIM-1 was seen in approximately half of (A) embryonal carcinomas and (B) yolk sac tumors. Yolk sac tumors were the only germ cell tumor with immunoreactivity for (C) PAX-2 and (D) PAX-8, seen in half/one-quarter of cases, respectively.